Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Conditions

Acute Ischemic Stroke · Cerebral Stroke

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The University of Arizona - College of Medicine, Tucson, Arizona, United States

    Contact: Study coordinator (Kaddouh, Firas) · firaskaddouh@arizona.edu
  • Mercy Medical Group, Carmichael, California, United States

    Contact: Study coordinator (Lucian Maidan, MD)
  • St. John's Regional Medical Center, Oxnard, California, United States

    Contact: Study coordinator (Mani Nezhad)
  • Sarasota Memorial Hospital, Sarasota, Florida, United States

    Contact: Study coordinator (Dr. Mauricio Concha)
  • Wellstar Kennestone Hospital, Marietta, Georgia, United States

    Contact: Study coordinator (Dr. Ovais Inamullah)
  • SSM Health Neurosciences, Bridgeton, Missouri, United States

    Contact: Study coordinator (Amer Alshekhlee, MD)
  • Hackensack University Medical Center at Paramus, Paramus, New Jersey, United States

    Contact: Study coordinator (Amory, Colum) · colum.amory@hmhn.org
  • Guilford Neurologic Associates Inc, Greensboro, North Carolina, United States

    Contact: Study coordinator (Dr. Pramod Sethi)
  • OSU Wexner Medical Center, Columbus, Ohio, United States

    Contact: Study coordinator (Yousef Hannawi)
  • Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

    Contact: Study coordinator (Reichwein, Raymond) · rreichwein@pennstatehealth.psu.edu
  • UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Dr Jussie Correia Lima)
  • CHI Memorial Neuroscience Institute, Chattanooga, Tennessee, United States

    Contact: Study coordinator (Thomas Devlin)
  • Houston Medical Neurological Institute, Houston, Texas, United States

    Contact: Study coordinator (David Chui, MD)
  • Memorial Hermann Hospital, Houston, Texas, United States

    Contact: Study coordinator (Mahan Shahrivari, MD)
  • Klinikum Altenburger Land GmbH, Altenburg, Altenburg, Germany

    Contact: Study coordinator (Joerg Berrouschot)
  • Universitaetsklinikum Goettingen, Göttingen, Lower Saxony, Germany

    Contact: Study coordinator (Ilko Maier)
  • Klinikum der Stadt Ludwigshafen gGmbh, Rhein, Ludwigshafen Am, Germany

    Contact: Study coordinator (Dr Simon Nagel)
  • Muhlenkreiskliniken (MKK) - Johannes Wesling Klinikum Minden - Neurologische Klinik, Minden, North Rhine-Westphalia, Germany

    Contact: Study coordinator (Dr Peter Schellinger)
  • Klinik fuer Neurologie, Stroke Unit und Fruehrehabilitation Dorstener Strae 151, Recklinghausen, Recklinghausen, Germany

    Contact: Study coordinator (Dr Stephan Klebe)
  • Charite-Universitaetsmedizin Berlin, Berlin, State of Berlin, Germany

    Contact: Study coordinator (Christian Nolte) · christian.nolte@charite.de
  • RHON-KLINIKUM Campus Bad Neustadt, Bad Neustadt an der Saale, Germany

    Contact: Study coordinator (Soda, Hassan) · h.soda.akut@neurologie-bad-neustadt.de
  • Universitaetsklinikum Erlangen, Erlangen, Germany

    Contact: Study coordinator (Gerner, Stefan) · stefan.gerner@uk-erlangen.de
  • Universitätsklinikum Essen AöR, Essen, Germany

    Contact: Study coordinator (Prof. Dr. med. Martin Köhrmann)
  • Universitätsklinikum Schleswig-Holstein AöR, Lübeck, Germany

    Contact: Study coordinator (Prof. Dr. George Royl)
  • University Hospital Tuebingen, Tübingen, Germany

    Contact: Study coordinator (Mengel, Anne Rose) · sven.poli@uni-tuebingen.de
  • Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

    Contact: Study coordinator (María Hernández Pérez)
  • Hospital Universitari Vall d'Hebron, Barcelona, Barcelona, Spain

    Contact: Study coordinator (Carlos Alberto Molina Cateriano)
  • Complejo Hospitalario Universitario de Albacete, Albacete, Castille-La Mancha, Spain

    Contact: Study coordinator (Dr Tomas Segura Martin)
  • Hospital Universitario La Paz, Madrid, Madrid, Spain

    Contact: Study coordinator (Exuperio Díez Tejedor)
  • Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Madrid, Spain

    Contact: Study coordinator (Dr Joaquin Carneado Ruiz)
  • Hospital Clínico Universitario Virgen de Arrixaca, El Palmar, Murcia, Spain

    Contact: Study coordinator (Dr Ana Morales Ortiz)
  • Hospital Universitario Virgen Macarena, Seville, Sevilla, Spain

    Contact: Study coordinator (Soledad Pérez Sánchez)
  • Hospital Universitari Joan XXIII, Tarragona, Tarragona, Spain

    Contact: Study coordinator (Dr Xavier Ustrell Roig)
  • Instituto de Investigación Biomédica de A Coruña, A Coruña, Spain

    Contact: Study coordinator (Dr Maria del Mar Castellanos Rodrigo)
  • Hospital Universitario Infanta Cristina (HUB), Badajoz, Spain

    Contact: Study coordinator (Dr Jose Maria Ramirez Moreno)
  • Hospital Universitario de Cruces, Barakaldo, Spain

    Contact: Study coordinator (Dr Mari Mar Freijo Guerrero)
  • Institut Catala d'Oncologia (ICO) - Hospital Universitari Doctor Josep Trueta, Girona, Spain

    Contact: Study coordinator (Dr Yolanda Silva Blas)
  • Hospital Universitario Ramon y Cajal, Madrid, Spain

    Contact: Study coordinator (Dr Jaime Masjuan Vallejo)
  • Hospital Clinico San Carlos, Madrid, Spain

    Contact: Study coordinator (Dr Jose Antonio Egido Herrero)
  • Medical Imbrain S.L., Melilla, Spain

    Contact: Study coordinator (Romero Imbroda, Jesus) · jesusromeroimbroda@gmail.com
  • Hospital Clinico Universitario de Santiago, Santiago, Spain

    Contact: Study coordinator (Dr Manuel Rodriguez Yanez)
  • Hospital Universitario Virgen del Rocio, Seville, Spain

    Contact: Study coordinator (Dr Francisco Moniche Alvarez)
  • Hospital Clinico Universitario de Valencia, Valencia, Spain

    Contact: Study coordinator (Dr. Alejandro Ponz)
  • Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain

    Contact: Study coordinator (Dr Irene Escudero Martinez)
  • Hospital Universitario Miguel Servet, Zaragoza, Spain

    Contact: Study coordinator (Dr Herbert Tejada Meza)
  • Fairfield General Hospital, Bury, Bury, United Kingdom

    Contact: Study coordinator (Dr Narayanamoorthi Saravanan)
  • National Hospital for Neurology & Neurosurgery, London, London, United Kingdom

    Contact: Study coordinator (Dr Richard Perry)
  • King's College Hospital NHS Foundation Trust, London, London, United Kingdom

    Contact: Study coordinator (Dr Yee Mah)
  • St. George's University Hospitals, London, London, United Kingdom

    Contact: Study coordinator (Zhang, Liqun) · liqun.zhang@stgeorges.nhs.uk
  • University Hospital Southampton, Southampton, Southampton, United Kingdom

    Contact: Study coordinator (Dr Richard Marigold)
  • New Cross Hospital - Royal Wolverhampton NHS Trust, Wolverhampton, Wolverhampton, United Kingdom

    Contact: Study coordinator (Dr Nasar Ahmad)
  • London North West University Healthcare NHS Trust - Northwick Park Hospital, Harrow, United Kingdom

    Contact: Study coordinator (Sivagnanaratnam, Aravinth) · a.sivagnanaratnam@nhs.net
  • Hospitals NHS Foundation Trust - Royal Victoria Infirmary RVI, Newcastle, United Kingdom

    Contact: Study coordinator (Dr. Anand Dixit)
  • Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom

    Contact: Study coordinator (Ferdinand, Phillip) · phillip.ferdinand@uhnm.nhs.uk
Study leads
  • Anil Gulati, MD, PhD

    Study Chair

    Pharmazz, Inc.